National Pharmacovigilance Research Center is a well-known brand in the professional pharmaceutical field. With their expertise and in-demand experience in pharmacovigilance, their team is highly regarded for their work. As a resident of the innovation fund Skolkovo since 2018, the center is dedicated to ensuring the safety and effectiveness of medicines and medical devices.

Their services include research, training, and a mobile application. They provide comprehensive reports on drug safety, risk management plans, and more, with a guarantee of efficient collaboration with healthcare professionals, consumers, and regulatory agencies. Led by Anatoliy Krasheninnikov, a pharmaceutical doctor with 50 publications on drug safety, the center's team, including Alena Sidorenko, Head of Promotion, has received praise for their professionalism and high qualifications.

Companies like Sigardis Rus and BIS have commended their approach to pharmacovigilance and the quality of their reports. The National Pharmacovigilance Research Center is committed to developing the field of pharmacovigilance, promoting health, and contributing to the Eurasian Economic Union's pharmacovigilance system